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Summary Fluorescence in situ hybridisation (FISH) has been used increasingly for gene mapping and
ordering probes on interphase and metaphase preparations. The association of consistent chromosomal
aberrations with certain malignancies allows the possibility of using interphase cytogenetics as a diagnostic
tool. In small round cell tumours of children accurate diagnosis may be difficult using existing methods. We
have therefore evaluated the diagnostic potential of this technique when applied to the characteristic t(11;22)
found in Ewing's sarcoma and peripheral neuroectodermal tumour (ES and PNET).
Interphase nuclei were prepared from normal human foreskin fibroblasts (HFF), two Ewing's sarcoma cell
lines and several fresh tumour biopsies. DNA probes each side of the breakpoint at 22ql2 were labelled with
biotin and digoxygenin, hybridised to chromosomes in interphase and detected in different colours.
Measurements between pairs of signals arising from each copy of chromosome 22 were taken and statistical
analysis performed.
There was a highly significant difference (P<0.0001) between the two populations of measurements
obtained (from nuclei with and without the t(11;22)). Studying four tumours and one further ES line (blind) it
was found that median values from 30 nuclei could correctly identify which samples contained the t(11;22).
This application of interphase cytogenetics contributes a reliable, accurate and conceptually simple diagnos-
tic test for ES and PNET. It may now be applied to other tumours with characteristic translocations,
amplifications or deletions when suitable probes are available. This approach is likely to become a routine in
clinical diagnosis.
Small round cell tumours in children and adolescents,
particularly neuroblastoma, Ewing's sarcoma, peripheral
neuroectodermal tumour (PNET), and rhabdomyosarcoma,
frequently present diagnostic difficulty, especially in their
most undifferentiated forms (Donner, 1991). Their histology
may be virtually identical, and electron microscopy,
immunocytochemistry, cytogenetic and molecular studies
may be necessary to define tumour type reliably. Correct
diagnosis is ofparamount importance to clinician and patient
alike for therapeutic decisions and prognosis.
Under these circumstances the finding of a chromosomal
abnormality in the tumour cells is invaluable. Consistent and
specific chromosome translocations have been found to be
associated with a number of human malignancies including
leukaemias and lymphoma (Dewald et al., 1985), and more
recently with solid tumours (Fletcher et al., 1991). These
include the t(11;22) (q24;ql2) in the majority of cases of
Ewing's sarcoma (Aurias et al., 1983; Turc-Carel et al., 1983)
and many PNETs (Donner, 1991; Whang Peng et al., 1984),
the t(2;13)(q35;ql4) in alveolar rhabdomyosarcoma (Donner,
1991), and del(lp) in neuroblastoma (Donner, 1991; Weith et
al., 1989). These characteristic chromosome aberrations can
be used reliably to distinguish the different tumours, and in
some cases can also give an indication of prognosis (Chris-
tiansen & Lampert, 1988). However, accurate karyotyping of
metaphase preparations from solid tumours is difficult due to
poor chromosome spreading and banding, and condensed or
fuzzy appearance of chromosomes. In addition, areas of
necrosis in the biopsy and a low mitotic index in the viable
material often result in few metaphases being obtained.
By utilising the technique of FISH on non-mitotic (inter-
phase) preparations these technical difficulties can be
avoided. Furthermore, by using direct preparations of fresh
material, culturing of tumour cells may be unnecessary, or
limited to 48 hours, avoiding possible selection of a highly
proliferative sub-population of tumour cells which may not
be representative. Longer term culture also tends to result in
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overgrowth of stromal cells which often infiltrate the tumour
tissue.
We have isolated DNA probes flanking the chromosome
22 breakpoint of the t(I1;22) in Ewing's sarcoma with which
we have determined whether or not the translocation is pre-
sent using FISH. Hybridised simultaneously to normal inter-
phase nuclei these probes are seen in association with one
another: the translocation disrupts this. Thus it has been
possible to make an accurate diagnosis even while the
molecular alteration at the breakpoint is not known.
In the underlying study we report our application of this
technique to a Ewing's sarcoma cell line with a known
karyotype, and show how we have developed this into a
quick and reliable diagnostic test.
Materials and methods
Samplepreparation
Interphase nuclei were prepared from normal human foreskin
fibroblasts (HFF), a human Ewing's sarcoma cell line RD-ES
(from American Type Culture Collection, 12301 Parklawn
Drive, Rockville, Maryland, 20852-1776 USA), and several
fresh tumour biopsies (from Great Ormond Street Hospital,
London).
The cell line was cultured in RPMI 1640, with 15% foetal
calf serum (FCS) (Gibco) and 1% glutamine at 37°C, with
5% CO2. Fibroblasts were grown in DMEM, 10% (FCS)
and 1% glutamine with 10% CO2. The tumours were cul-
tured in RPMI, 15% FCS, 1% glutamine, MITO+serum
extender and CR-Bovine pituitary extract (both from Col-
laborative Research Incorporated, Two Oak Park, Bedford,
MA 01730) and 5% CO2. In order to synchronise the cells in
GI thymidine was added to confluent cell cultures at a final
concentration of 300jg ml-' for 16 h. This was washed out
and the cells left for a further 8 h before being removed by
trypsinisation and resuspended in 75 mM KCI for 10 min.
Fixation was in 3:1 methanol:glacial acetic acid, and nuclei
were dropped onto cleaned glass slides.
Slides were aged for at least one week at 4°C before use, or
artificially aged by baking at 65'C for 2-4 h. Immediately
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prior to hybridisation, nuclei (on slides) were denatured in
70% formamide, 2 x SSC at 70°C for 2 min, then dehydrated
through an ethanol series of 70% at 4°C, 95% and absolute
ethanol (at room temperature) for 3 min each.
Metaphase spreads were obtained for karyotyping from
the cell line and the tumours during exponential growth with
addition of colcemid for the final 3 h. Slides were then made
according to routine cytogenetic practice and chromosomes
were G banded after immersion in 2 x SSC at 60°C for 5 min
and stained with 1:4 Wright's stain:50% Sorenson's buffer.
(Figure 1).
DNA probes
The two DNA probes used were the closest to the breakpoint
at 22q12 that we had available at the time. CosS262 is a
35 kb cosmid derived from an endclone (D22S262) of a YAC
located immediately above the breakpoint (Shipley et al.,
submitted). CosLIF is a 45 kb cosmid for the Leukaemia
Inhibitory Factor, isolated using a 300 bp probe derived from
the LIF exon (Gough et al., 1988; Budarf et al., 1989; Selleri
et al., 1991). (Figure 2).
The probes were labelled by nick-translation with biotin-
11-dATP (BRL Bio-nick kit) or else with digoxygenin-11-
dUTP (Boehringer, Mannheim, Germany) according to the
instructions of the supplier. The probes were purified through
a Sephadex G50 column and precipitated with salmon sperm
DNA and E. coli tRNA.
In situ hybridisation
(Williams et al., 1991) Hybridisation and detection were per-
formed according to our modification of the technique des-
cribed by Pinkel et al (1986). For one colour FISH 40 ng of
each biotinylated probe was mixed with 10gg of unlabelled
CotI DNA (Gibco BRL). For two colour experiments 80 ng
of LIF cosmid labelled with biotin and 60 ng of cosS262
labelled with digoxygenin were mixed with 10 ig of Cotl
DNA. We have found these quantities to be optimal in
producing signals of equal intensity with minimal back-
ground fluorescence. Cotl DNA has been found to be more
efficient at reducing signal from repetitive sequences than
total human DNA (Landegent et al., 1987). The probe/
competitor mixture was dried in a vacuum centrifuge and
resuspended in 11 jd hybridisation mix (10% dextran sul-
phate, 2 x SSC, 50% formamide, 1% Tween 20, pH 7), de-
natured at 75°C, chilled on ice and preannealed at 37°C for
up to 3 h. Hybridisation was then performed overnight at
37°C under a sealed coverslip.
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Figure 1 Partial karyotype of Ewing's sarcoma showing typical
t(l1;22).
Post hybridisation washes were in 50% formamide,
2 x SSC, pH 7 (3 times) and 2 x SSC, pH 7 (3 times), all at
42°C. Slides were then washed in 4 x SSC, 0.05% Tween 20,
pH 7 (SSCT) and preincubated with SSCT plus 5% low fat
dried milk (Marvel) (SSCTM). Signal detection for one col-
our was carried out by incubations with 5 yg ml-' FITC
conjugated avidin DCS (Vector labs) in SSCTM, followed by biotinylated anti-avidin (Vector labs) and a second round of
FITC-avidin DCS (both at 5 fgml-') to amplify the signal. Two colour detection was by incubation with sheep anti-
digoxygenin polyclonal antibody (Boehringer Mannheim) at
0.4jig ml-' plus avidin-texas-red at 2ygml-', both in
SSCTM. This was followed by rabbit anti-sheep IgG con-
jugated to FITC (Vector labs) at 30jig ml-'. Then bio-
tinylated anti-avidin at 5yg ml-' was used alone and finally
another round of avidin-texas-red. All incubations were at
37°C for 30 min and the slides were washed between incuba-
tions with SSCT at 42°C. Finally they were washed in phos-
phate buffered saline and dehydrated. Slides were mounted in
Citifluor (Citifluor Ltd., London) containing propidium
iodide 0.5 lag ml-' for one colour visualisation or DAPI
(diamidino-2-phenyl-indole dihydrochloride; Sigma) 0.1 tLg ml-' for two colours. Images were photographed on Scotch
chrome 640T slide film using a Zeiss Axiophot microscope
with Zeiss filter set 9.PRO for one colour or Omega Optical
dual band pass filter for two colour detection.
Evaluation ofFISH results
The two probes CosS262 and CosLIF were applied to slides
of nuclei of HFF and RD-ES. Initially experiments were
done in one colour (i.e. both probes labelled with biotin and
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Figure 2 Diagram of t( 1;22) showing positions of probes in normal and translocated chromosomes.130 C. TAYLOR et al.
detected with FITC (green)). To ensure that measurements
were between different probes the experiments were repeated
in two colours. CosS262 (labelled with digoxygenin) was
detected with FITC and cosLIF (labelled with biotin)
detected with texas-red. Six slide preparations (from two
separate cultures) were scanned for each of HFF and RD-
ES. HFF and RD-ES nuclei were photographed and the
relative distances between signals analysed by taking
measurements (in millimetres) directly from slides projected
onto a screen (Trask et al., 1989).
In normal (control) cells the expected result is two pairs of
signals indicating the positions of the two adjacent probes on
each copy of chromosome 22. In two colour experiments
each pair consists of one red and one green signal (cosLIF
and cosS262 respectively). Cells carrying the
t(l 1;22)(q24;q12) diagnostic of Ewing's sarcoma should show
one pair of signals (on the normal chromosome 22) and two
separate signals i.e. cosS262 remaining on chromosome 22
above the breakpoint and cosLIF translocated to chromo-
some 11 (Figures 3 and 4).
Statistical methods
Ratios of the distances recorded for the two pairs of signals
in each nucleus (two colour experiments only) were cal-
culated for the HFF and RD-ES nuclei. The larger distance
was always used as a numerator for the ratio since there was
no obvious ordering between the pairs of measurements; all
values were therefore greater than or equal to one. In order
to assess whether the HFF ratios differed from the RD-ES
ratios, a two sample rank test called the Mann-Whitney test
was used (Altman, 1991). This test assumes that the ratios
observed in the HFF and RD-ES nuclei are random samples
taken from two populations characterised by similar varia-
tion but different medians.
In order to determine how many pairs of measurements
should be carried out in practice in the diagnosis of tumours
with the t(I 1;22) we have used a computer-intensive method
known as 'bootstrap' (Efron & Tibshirani, 1986). This
method allowed us to simulate the populations of HFF and
RD-ES ratios from which the original observations were
Figure 3 Photographs showing FISH on normal HFF nuclei (red signal is cosLIF, green signal is cosS262).
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sampled. From these two populations new random samples
of different sizes could then be generated.
We have considered sample sizes of 10, 20, 30 and 40 pairs
of measurements and we have examined the distribution of
HFF and RD-ES values corresponding to each sample size.
To smooth random fluctuations 100 replicates of each sample
size were generated from each of the two populations and the
median value of these computed. The distribution of the
median values found for different sample sizes of the HFF
data was then compared with that of the RD-ES data.
Results
A total of 130 pairs of measurements were taken from nor-
mal HFF nuclei and 224 pairs from the RD-ES cell line.
Measurements were only taken from nuclei where all four
signals were clearly visible, and care was taken that no
confusion arose from excessive background signal. The
experiments were repeated if the background was too
marked. In a few nuclei a double dot was visible for one or
more of the signals, probably due to chromatid duplication
in poorly synchronised cells. Often this made no difference to
the measurements taken, but in cases where a difference
would result from selecting one or other half of the doublet
the nucleus was excluded from the study. Occasionally, due
to the configuration of the four signals, it was not possible to
decide which ones constituted a pair. In these cases the
nucleus was excluded from the study. Bunched or overlap-
ping nuclei were not included to prevent inadvertent measur-
ing between signals arising in different cells. On the HFF
slides 46% of the nuclei met these criteria for inclusion in the
results. Hybridisation on the cell line was marginally less
efficient allowing interpretation of 40% of nuclei. There was
little variability between experiments provided the standard
conditions detailed above were adhered to. In a very few
RD-ES nuclei there was an extra copy of chromosome 22,
i.e. there were three pairs of signals. In each case two pairs
had signals very close together, while the third pair was
widely separated, so it appeared that there were two normal
copies of chromosome 22 and one with a translocation. For
the purposes of the study an average of the two similar
measurements was taken.
Statistical analysis
A ratio was calculated (as above) for each pair of
measurements. This approach means that no absolute
measurements are compared, even between nuclei in the same
preparation, so that differences between the various types of
cells used become irrelevant. There were a total of 130 values
for the normal cells and 224 values for the tumour cells (all
to two decimal places). Both sets of results had highly
skewed distributions as shown in the histograms. (Figures 5
and 6). For the normal nuclei the median ratio was 1.39 (1st
quartile 1.16, 3rd quartile 1.87) with a maximum value of
4.20 and minimum of 1.00. For the RD-ES cell line the
median was 4.80 (1st quartile 2.40, 3rd quartile 6.97) with a
maximum of 17.33 and minimum of 1.00. This means that in
half the normal nuclei one pair of signals was at most 1.39
times further apart than the other pair, whilst the equivalent
figure for the tumour cell line nuclei was 4.80 times. To
compare the distribution of the HFF ratios with that of the
RD-ES ratios the Mann-Whitney test was used, recom-
mended because of the skewed distribution of the values
(which was also found when they were log-transformed). The
test showed a highly significant result (W = 50957.5,
P<0.0001) indicating that the difference between the
medians in the two sets of data was significantly different
from zero.
We have simulated the population from which the original
sample was taken and then generated from this new popula-
tion new (random) samples of different sizes. For each sam-
ple size this has been repeated 100 times. We have then
compared the medians found in the samples ofdifferent sizes.
(Table I).
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Figure 5 Histogram of ratios from HFF nuclei.
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Figure 6 Histogram of ratios from RD-ES nuclei.
With a sample size of 30 measurements meeting the study
criteria we have a 95% confidence interval for the median
ratio in nuclei without the t(ll;22) of (1.19,1.59) and a 95%
confidence interval for the median ratio in nuclei with
t(ll;22) of (3.63,6.23). The two intervals are well apart. A
sample size of 40 only slightly improves the discrimination
between the two groups.
Application ofthe test to tumour samples
Four tumour samples and one more cell line (EW11, from G.
Lenoir, (Turc-Carel et al., 1983)) from which nuclei had
already been prepared underwent FISH exactly as described
above. All of these had been karyotyped previously and
diagnoses made. One slide was processed for each sample:
the number of evaluable nuclei was satisfactory on all five
slides, so no part of the experiment had to be repeated.
Assessment of results by fluorescent microscopy was carried
out blind by one observer (CT). The first 30 nuclei on each
slide which met the criteria for the study were included. For
each of these an estimate (by eye) of the ratio of the two
distances between pairs of signals was recorded. The
estimates were limited to 1, 1.5, 2, 3, 4, 5, 6 and >6. In
addition these same 30 nuclei were photographed,
measurements were taken and ratios were calculated as132 C. TAYLOR et al.
Table I Summary of the median values found in 100 replicates
Cell without t(JJ;22) Cell with t(11;22)
Sample size Mean (SE) Range Mean (SE) Range
10 1.44 (0.18) [1.14,2.06] 4.76 (1.21) [2.19,8.28]
20 1.45 (0.16) [1.15,2.00] 4.75 (0.90) [2.87,6.82]
30 1.40 (0.10) [1.20,1.77] 4.93 (0.65) [2.67,6.56]
40 1.39 (0.10) [1.20,1.74] 4.83 (0.61) [3.52,6.50]
previously. The median values for the ratios of each of the
five samples was found to be comparable by eye and by
measuring. The cell line and tumour no. 3 (both known to
have t(11;22)), produced medians within the 95% confidence
interval for the population bearing the translocation. The
remaining three samples had values within the interval for
not bearing the translocation. (Table II).
Discussion
The potential of hybridising markers to interphase nuclei to
diagnose tumours bearing rearrangements, deletions and
amplifications has been discussed for some time (Tkachuk et
al., 1991; Selleri et al., 1991) but we believe this study to be
the first to define and quantify a diagnostic test for a specific
tumour. The method can now be applied to unidentified
tumour samples with the knowledge that an accurate diag-
nosis can be made after microscopic examination of 30
nuclei. The processing of a new biopsy or operation specimen
can take as little as 5-10 working days. This includes short
term culture, harvesting ofnuclei, slide making and detection
of signal with fluorochromes.
We have tested these criteria on four primary tumour
samples and one cell line for which we have a firm diagnosis.
In each case both the precise measurement of 30 cells and 'by
eye' estimation of the ratio of distances between pairs of
signals has led to a correct diagnosis of ES/PNET or not
ES/PNET. Making this assessment down the microscope did
not prove to be time consuming, taking an average of 1 h to
record results for 30 nuclei (including photography). We do
not, in the light of these data, believe that photography and
formal measurement is necessary to obtain a reliable result,
further reducing the time per slide. So although the initial
quantitation of results for each new probe is laborious, the
finished product is an efficient test which will produce an
accurate diagnosis, based on the presence or absence of a
specific translocation, sufficiently quickly to make a useful
contribution to patient management.
For the study of a translocation the probes need to be as
close to either side of the breakpoint as possible to limit the
variability of measurements obtained in control nuclei. If the
probes are too widely separated a much larger number of
nuclei would have to be examined before a reliable result was
obtained. At the time of writing we do not know how far
apart cosS262 and cosLIF are, but we can infer from the cell
to cell variation in the distance between the probes that they
are more than one megabase apart. Published data show that
at a DNA distance of greater than one megabase the linear
relationship with interphase distance is lost (Lawrence et al.,
1990), so a meaningful estimate of the distance between
cosLIF and cosS262 cannot be made. We have since pro-
duced another cosmid which, from our ordering work, maps
between cosS262 and the breakpoint (Shipley et al., submit-
ted 1992). This is currently being studied to see whether if it
were used instead of cosS262 the resulting diagnostic test
would require even fewer nuclei to be examined. However,
some normal nuclei are unavoidably present in the tumour
samples, so sufficient nuclei must always be viewed to
minimise the risk of false negative results. If the median ratio
for 30 nuclei in a particular specimen falls between the two
95% confidence intervals given for the two populations, then
the number of nuclei included should be increased until a
meaningful result is reached.
Inevitably this technique will not make a diagnosis of
Ewing's sarcoma or PNET in those cases which do not carry
Table II Results for five samples tested blind according to the
described criteria
Median ratio Median ratio Diagnosis Known
Slide no (by eye) (measured) (from test) diagnosis
1 1.5 1.53 Not ES/PNET Nb
2 1.5 1.44 Not ES/PNET Rh
3 4.0 3.77 ES/PNET PNET
4 1.5 1.50 Not ES/PNET Nb
5 4.0 5.55 ES/PNET ES cell line
(ES = Ewing's sarcoma; PNET = peripheral neuroectodermal
tumour; Nb = neuroblastoma; Rh = rhabdomyosarcoma)
the translocation. According to recent studies this means
17% of Ewing's sarcoma and 48% of PNET may be missed
(Donner et al., 1991; Gorman et al., 1991). However, with
the application of increasingly sophisticated molecular tech-
nology, the proportion of tumours believed to be without the
translocation is reducing and it may now be hypothesised
that apparently t(l1;22) negative cases in reality have com-
plex translocations or insertions involving 22ql2. This situa-
tion can be compared to that of Philadelphia negative CML,
in which bcr-abl fusion can be detected by molecular
methods in cytogenetically Ph negative samples (Tkachuk et
al., 1990; Shtalrid et al., 1988). If this proves to be the case it
is advantageous at this stage to use probes which are outside
the critical area around the breakpoint on chromosome 22,
since otherwise possible variants (perhaps currently regarded
as t(l1;22) negative) could also be missed. Thus it is possible
that this test will pick up a higher proportion of tumours
with a translocation involving chromosome 22. In order to
pick up t(l1;22) negative cases involving small insertion of
material into 22ql2 it may be necessary to use probes from
around the breakpoint region on chromosome 11. It is our
aim to study archival material and to correlate our results
with previous data on the presence or absence of t(l1;22).
Once the sequence at the breakpoint is cloned, probes
immediately flanking the breakpoint could be utilised so that
the presence of the translocation could be detected by finding
two separate signals and a two colour doublet in affected
nuclei and four separate signals in nuclei not bearing the
t(ll;22). This would be achieved by labelling the sequence
centromeric to the breakpoint on chromosome 11 in one
colour and the sequence telomeric to the breakpoint on
chromosome 22 in another colour. A similar approach is
already being explored for the diagnosis of CML (Tkachuk
et al., 1990). The disadvantage of this is that if there are
variations in the exact site of the breakpoint, or in the critical
flanking sequences, different probes will be required to seek
each variant.
In conclusion, we have described how interphase
cytogenetics can be used to provide an accurate diagnostic
test which should prove reliable if it is carried out by person-
nel familiar with the techniques involved. The relatively short
time taken from receipt of the tissue sample to interpretation
of results means that this technique is at least comparable to
existing histological and cytochemical methods of diagnosis
of these tumours. However, a positive result, when obtained,
may be considerably less equivocal than the results of the
existing tests. This will have obvious benefits in the clinical
setting, enabling the oncologist to plan optimal therapy, and
allowing frank discussion with patients and families of the
natural history of the disease and its prognosis at the com-
mencement of treatment. We believe that this approach with
interphase FISH will be extended to other malignancies with
translocations, deletions or amplifications in the near future,
and will before long become a routine in clinical diagnosis.
Note added in proof
Delattre et al. (Nature, 359, 162-165) have just published the cloning
of the t(ll;22) breakpoint.
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